| Filed On | Filing |
|---|---|
| 06 May 2026 |
8-K/A: Results of Operations and Financial Condition
MASON, Ohio, May 6, 2026 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced... |
| 29 Oct 2025 |
8-K/A: Results of Operations and Financial Condition
MASON, Ohio, October 29, 2025 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today anno... |
| 27 Feb 2024 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On January 4, 2024 AtriCure, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) reporting that the Company’s Board of Directors (the “Board”) elected Shlomi Nachman to serve as a director until the Company’... |
| 24 Oct 2019 | 8-K/A: Financial Statements and Exhibits |
| 02 Mar 2017 | 8-K/A: Results of Operations and Financial Condition |
| 10 Nov 2015 | 8-K/A: Financial Statements and Exhibits |
| 13 Mar 2014 | 8-K/A: Financial Statements and Exhibits |
Loading...
